Elevance Health (ELV) is scheduled to report Q2 earnings on July 16, 2026. Analysts estimate EPS of $6.21 and quarterly revenue of $48.61B.
In the most recent quarter (Q1), Elevance Health reported EPS of $12.58, beating estimates of $10.74 by 0.17%. Revenue came in at $49.49B, exceeding the estimate of $47.98B by 0.03%.
Elevance Health has beaten EPS estimates in 3 consecutive quarters.
Over the last 4 quarters, Elevance Health has averaged an EPS surprise of 0.12% and a revenue surprise of 0.02%.
Analyze the earnings history of Elevance Health using advanced sorting and filters.
The chart below shows Elevance Health's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Elevance Health's reported revenue compared to analyst estimates over recent quarters.
Elevance Health (ELV) is scheduled to report earnings on July 16, 2026. The last reported earnings were for reported on April 22, 2026 for Q1.
The Actual EPS was $12.58, which beat the estimate of $10.74.
The Actual Revenue was $49.49B, which beat the estimate of $47.98B.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2026-04-22 | $12.58 | $10.74 | 17.1 % |
| Q4 | 2026-01-28 | $3.33 | $3.10 | 7.42 % |
| Q3 | 2025-10-21 | $6.03 | $4.96 | 21.6 % |
| Q2 | 2025-07-17 | $8.84 | $9.19 | -3.81 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2026-04-22 | $49.49B | $47.98B | 3.15 % |
| Q4 | 2026-01-28 | $49.31B | $49.47B | -0.32 % |
| Q3 | 2025-10-21 | $50.09B | $49.51B | 1.17 % |
| Q2 | 2025-07-17 | $49.42B | $48.21B | 2.50 % |